Literature DB >> 27385312

[Pharmacological treatments for fatigue associated with palliative care].

D L Dräger1, S Schmidt2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27385312     DOI： 10.1007/s00120-016-0170-x

Source DB:  PubMed          Journal:  Urologe A        ISSN： 0340-2592            Impact factor:   0.639


× No keyword cloud information.
  11 in total

1.  Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of Cancer Survivors.

Authors:  Qiuling Shi; Tenbroeck G Smith; Jared D Michonski; Kevin D Stein; Chiewkwei Kaw; Charles S Cleeland
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

2.  L-carnitine supplementation in patients with advanced cancer and carnitine deficiency: a double-blind, placebo-controlled study.

Authors:  Ricardo A Cruciani; Ella Dvorkin; Peter Homel; Bruce Culliney; Stephen Malamud; Jeanne Lapin; Russell K Portenoy; Nora Esteban-Cruciani
Journal:  J Pain Symptom Manage       Date:  2008-09-21       Impact factor: 3.612

Review 3.  Effects of exercise on cancer-related fatigue.

Authors:  F C Dimeo
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

Review 4.  Patients' experiences with cancer-related fatigue: a review and synthesis of qualitative research.

Authors:  Jane A Scott; Kathryn E Lasch; Andrea M Barsevick; Elisabeth Piault-Louis
Journal:  Oncol Nurs Forum       Date:  2011-05       Impact factor: 2.172

5.  How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists.

Authors:  S Newell; R W Sanson-Fisher; A Girgis; A Bonaventura
Journal:  Cancer       Date:  1998-10-15       Impact factor: 6.860

6.  L-carnitine supplementation for the management of fatigue in patients with cancer: an eastern cooperative oncology group phase III, randomized, double-blind, placebo-controlled trial.

Authors:  Ricardo A Cruciani; Jenny J Zhang; Judith Manola; David Cella; Bilal Ansari; Michael J Fisch
Journal:  J Clin Oncol       Date:  2012-09-17       Impact factor: 44.544

7.  Donepezil for cancer fatigue: a double-blind, randomized, placebo-controlled trial.

Authors:  Eduardo Bruera; Badi El Osta; Vicente Valero; Larry C Driver; Be-Lian Pei; Loren Shen; Valerie A Poulter; J Lynn Palmer
Journal:  J Clin Oncol       Date:  2007-08-10       Impact factor: 44.544

8.  L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial.

Authors:  Matthias Kraft; Kathleen Kraft; Simone Gärtner; Julia Mayerle; Peter Simon; Eckhard Weber; Kerstin Schütte; Jens Stieler; Heide Koula-Jenik; Peter Holzhauer; Uwe Gröber; Georg Engel; Cornelia Müller; You-Shan Feng; Ali Aghdassi; Claudia Nitsche; Peter Malfertheiner; Maciej Patrzyk; Thomas Kohlmann; Markus M Lerch
Journal:  Nutr J       Date:  2012-07-23       Impact factor: 3.271

9.  Age- and sex-standardised prevalence rates of fatigue in a large hospital-based sample of cancer patients.

Authors:  S Singer; S Kuhnt; R Zwerenz; K Eckert; D Hofmeister; A Dietz; J Giesinger; J Hauss; K Papsdorf; S Briest; A Brown
Journal:  Br J Cancer       Date:  2011-07-12       Impact factor: 7.640

Review 10.  Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008.

Authors:  Ali Montazeri
Journal:  Health Qual Life Outcomes       Date:  2009-12-23       Impact factor: 3.186
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.